DOI: 10.17116/pain20262403182 ISSN: 2219-5297
Resolution of the Expert Council “Non-steroidal anti-inflammatory drugs in the treatment of non-specific back pain and radiculopathy in the 2026 RASP guidelines”
A.E. Barulin, M.A. Bakhtadze, O.S. Davydov, F.I. Devlikamova, D.A. Iskra, P.P. Kalinsky, A.E. Karateev, M.L. Kukushkin, O.V. Kurushina, T.I. Nasonova, A.P. Rachin, A.V. Sergeev, M.V. Churyukanov, N.N. YakhnoIn June 2025, an Expert Council of the Russian Association for the Study of Pain (RASP) was held. Specialists discussed the role of nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of nonspecific (musculoskeletal) lower back pain. The meeting presented data from studies of efficacy and safety of aceclofenac, ketoprofen, lornoxicam, nimesulide, pelubiprofen, tenoxicam in the treatment of musculoskeletal back pain.